| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 122, 71-82, Copyright © 1986 by American Society for Investigative Pathology
REGULAR ARTICLES |
RJ Levy, FJ Schoen, FS Sherman, J Nichols, MA Hawley and SA Lund
Although collagen-containing implants are widely used in various surgical applications, there has been relatively little attention paid to the possibility that this type of biomaterial may undergo pathologic calcification which could compromise its function. The present study reports for the first time the calcification of a series of implants of purified collagen sponges prepared with graded degrees of aldehyde- induced cross-linkages (assessed by shrinkage-temperature, wetting time, and collagenase digestibility). Type I collagen sponges were pretreated with either glutaraldehyde (0.1% to 2.0% aqueous solution, for 5-180 minutes) or formaldehyde (as vapors for 15 minutes to 15 hours), and implanted subcutaneously for 21 days in weanling rats. Although specimens not pretreated with either aldehyde reagent and the formaldehyde sponges pretreated for 15 minutes were resorbed without evidence of calcification, all other aldehyde-pretreated implants mineralized. The degree of calcification did not correlate with extent of cross-linking. Formaldehyde-pretreated implants calcified more extensively (Ca2+ = 87.8 +/- 2.8 micrograms/mg, mean +/- standard error of the mean; n = 58) than did glutaraldehyde-pretreated implants (Ca2+ = 40.9 +/- 1.4 micrograms/mg; n = 52). It is concluded that both glutaraldehyde- and formaldehyde-pretreated Type I collagen sponges calcify after subdermal implantation in young rats. Although aldehyde pretreatment of Type I collagen sponge implants is a prerequisite for their eventual mineralization, the threshold level of aldehyde-induced cross-linking required to potentiate their maximal pathologic calcification is low.
This article has been cited by other articles:
![]() |
F. J. Schoen and R. J. Levy Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention Ann. Thorac. Surg., March 1, 2005; 79(3): 1072 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. G. Paez and E. Jorge-Herrero Assessment of Pericardium in Cardiac Bioprostheses: A Review J Biomater Appl, April 1, 1999; 13(4): 351 - 388. [Abstract] [PDF] |
||||
![]() |
K. M. Kim, G. A. Herrera, and H. D. Battarbee Role of Glutaraldehyde in Calcification of Porcine Aortic Valve Fibroblasts Am. J. Pathol., March 1, 1999; 154(3): 843 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Rao and C. Shanthi Reduction of Calcification by Various Treatments in Cardiac Valves J Biomater Appl, January 1, 1999; 13(3): 238 - 268. [Abstract] [PDF] |
||||
![]() |
M. Grabenwoger, J. Sider, F. Fitzal, C. Zelenka, U. Windberger, M. Grimm, A. Moritz, P. Bock, and E. Wolner Impact of Glutaraldehyde on Calcification of Pericardial Bioprosthetic Heart Valve Material Ann. Thorac. Surg., September 1, 1996; 62(3): 772 - 777. [Abstract] [Full Text] |
||||
![]() |
G. Golomb Controlled Release of Diphosphonates from Synthetic Polymers to Inhibit Calcification J Biomater Appl, January 1, 1987; 2(2): 266 - 289. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |